1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33179
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSingh, K P-
dc.contributor.authorCarvalho, A C C-
dc.contributor.authorCentis, R-
dc.contributor.authorD Ambrosio, L-
dc.contributor.authorMigliori, G B-
dc.contributor.authorMpagama, S G-
dc.contributor.authorNguyen, B C-
dc.contributor.authorAarnoutse, R E-
dc.contributor.authorAleksa, A-
dc.contributor.authorvan Altena, R-
dc.contributor.authorBhavani, P K-
dc.contributor.authorBolhuis, M S-
dc.contributor.authorBorisov, S-
dc.contributor.authorvan T Boveneind-Vrubleuskaya, N-
dc.contributor.authorBruchfeld, J-
dc.contributor.authorCaminero, J A-
dc.contributor.authorCarvalho, I-
dc.contributor.authorCho, J G-
dc.contributor.authorDavies Forsman, L-
dc.contributor.authorDedicoat, M-
dc.contributor.authorDheda, K-
dc.contributor.authorDooley, K-
dc.contributor.authorFurin, J-
dc.contributor.authorGarcía-García, J M-
dc.contributor.authorGarcia-Prats, A-
dc.contributor.authorHesseling, A C-
dc.contributor.authorHeysell, S K-
dc.contributor.authorHu, Y-
dc.contributor.authorKim, H Y-
dc.contributor.authorManga, S-
dc.contributor.authorMarais, B J-
dc.contributor.authorMargineanu, I-
dc.contributor.authorMärtson, A-G-
dc.contributor.authorMunoz Torrico, M-
dc.contributor.authorNataprawira, H M-
dc.contributor.authorNunes, E-
dc.contributor.authorOng, C W M-
dc.contributor.authorOtto-Knapp, R-
dc.contributor.authorPalmero, D J-
dc.contributor.authorPeloquin, C A-
dc.contributor.authorRendon, A-
dc.contributor.authorRossato Silva, D-
dc.contributor.authorRuslami, R-
dc.contributor.authorSaktiawati, A M I-
dc.contributor.authorSantoso, P-
dc.contributor.authorSchaaf, H S-
dc.contributor.authorSeaworth, B-
dc.contributor.authorSimonsson, U S H-
dc.contributor.authorSingla, R-
dc.contributor.authorSkrahina, A-
dc.contributor.authorSolovic, I-
dc.contributor.authorSrivastava, S-
dc.contributor.authorStocker, S L-
dc.contributor.authorSturkenboom, M G G-
dc.contributor.authorSvensson, E M-
dc.contributor.authorTadolini, M-
dc.contributor.authorThomas, T A-
dc.contributor.authorTiberi, S-
dc.contributor.authorTrubiano, J-
dc.contributor.authorUdwadia, Z F-
dc.contributor.authorVerhage, A R-
dc.contributor.authorVu, D H-
dc.contributor.authorAkkerman, O W-
dc.contributor.authorAlffenaar, J W C-
dc.contributor.authorDenholm, J T-
dc.date.accessioned2023-06-30T06:19:30Z-
dc.date.available2023-06-30T06:19:30Z-
dc.date.issued2023-07-01-
dc.identifier.citationThe International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease 2023; 27(7)en_US
dc.identifier.issn1815-7920-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/33179-
dc.description.abstractBACKGROUND: Adverse effects (AE) to TB treatment cause morbidity, mortality and treatment interruption. The aim of these clinical standards is to encourage best practise for the diagnosis and management of AE.METHODS: 65/81 invited experts participated in a Delphi process using a 5-point Likert scale to score draft standards.RESULTS: We identified eight clinical standards. Each person commencing treatment for TB should: Standard 1, be counselled regarding AE before and during treatment; Standard 2, be evaluated for factors that might increase AE risk with regular review to actively identify and manage these; Standard 3, when AE occur, carefully assessed and possible allergic or hypersensitivity reactions considered; Standard 4, receive appropriate care to minimise morbidity and mortality associated with AE; Standard 5, be restarted on TB drugs after a serious AE according to a standardised protocol that includes active drug safety monitoring. In addition: Standard 6, healthcare workers should be trained on AE including how to counsel people undertaking TB treatment, as well as active AE monitoring and management; Standard 7, there should be active AE monitoring and reporting for all new TB drugs and regimens; and Standard 8, knowledge gaps identified from active AE monitoring should be systematically addressed through clinical research.CONCLUSION: These standards provide a person-centred, consensus-based approach to minimise the impact of AE during TB treatment.en_US
dc.language.isoeng-
dc.titleClinical standards for the management of adverse effects during treatment for TB.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleThe International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Diseaseen_US
dc.identifier.affiliationDepartment of Infectious diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australiaen_US
dc.identifier.affiliationLaboratório de Inovações em Terapias, Ensino e Bioprodutos (LITEB), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.en_US
dc.identifier.affiliationServizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Tradate, Italy.en_US
dc.identifier.affiliationPublic Health Consulting Group, Lugano, Switzerland.en_US
dc.identifier.affiliationKilimanjaro Christian Medical University College, Moshi, United Republic of Tanzania, Kibong´oto Infectious Diseases Hospital, Sanya Juu, Siha, Kilimanjaro, United Republic of Tanzania.en_US
dc.identifier.affiliationWoolcock Institute of Medical Research, Viet Nam and University of Sydney, NSW, Australia.en_US
dc.identifier.affiliationDepartment of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.en_US
dc.identifier.affiliationGrodno State Medical University, Grodno, Belarus.en_US
dc.identifier.affiliationAsian Harm Reduction Network and Medical Action Myanmar, Yangon, Myanmar.en_US
dc.identifier.affiliationIndian Council of Medical Research-National Institute for Research in Tuberculosis, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.en_US
dc.identifier.affiliationDepartment of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.en_US
dc.identifier.affiliationMoscow Research and Clinical Center for Tuberculosis Control, Moscow, Russia.en_US
dc.identifier.affiliationDepartement of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.en_US
dc.identifier.affiliationDepartement of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, Stokholm, Swedenen_US
dc.identifier.affiliationDepartment of Pneumology. University General Hospital of Gran Canaria "Dr Negrin", Las Palmas, Spainen_US
dc.identifier.affiliationPaediatric Department, Vila Nova de Gaia Hospital Centre, Vila Nova de Gaia Outpatient Tuberculosis Centre, Vila Nova de Gaia, Portugal.en_US
dc.identifier.affiliationSydney Infecious Diseases Institute (Sydney ID), The University of Sydney, Sydney, NSW, Australia, Westmead Hospital, Sydney, NSW, Australiaen_US
dc.identifier.affiliationDepartement of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, Stokholm, Swedenen_US
dc.identifier.affiliationDepartment of Infectious Diseases, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.en_US
dc.identifier.affiliationCentre for Lung Infection and Immunity Unit, Department of Medicine, Division of Pulmonology and UCT Lung Institute, University of Cape Town, Cape Town, South Africaen_US
dc.identifier.affiliationDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.en_US
dc.identifier.affiliationDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.en_US
dc.identifier.affiliationTuberculosis Research Programme, SEPAR (Sociedad Española de Neumología y Cirugía Torácica), Barcelona, Spain.en_US
dc.identifier.affiliationDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Tygerberg, South Africaen_US
dc.identifier.affiliationParramatta Chest Clinic, Parramatta, NSW, Australia.en_US
dc.identifier.affiliationDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, USA.en_US
dc.identifier.affiliationDepartment of Epidemiology, School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, China.en_US
dc.identifier.affiliationSydney Infectious Diseases Institute (Sydney ID), The University of Sydney, Sydney, NSW, Australia, Westmead Hospital, Sydney, NSW, Australia, School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.en_US
dc.identifier.affiliationTuberculosis Department Latin American Society of Thoracic Diseases, Lima, Peru.en_US
dc.identifier.affiliationDepartment of Infectious Diseases and Microbiology, The Children´s Hospital at Westmead, Westmead, NSW, Australia.en_US
dc.identifier.affiliationDepartment of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.en_US
dc.identifier.affiliationCentre of Excellence in Infectious Diseases Research, Antimicrobial Pharmacodynamics and Therapeutics Group, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.en_US
dc.identifier.affiliationClínica de Tuberculosis, Instituto Nacional de Enfermedades Respiratorias, México City, Mexico.en_US
dc.identifier.affiliationDivision of Paediatric Respirology, Department of Child Health, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin Hospital, Bandung, Indonesia.en_US
dc.identifier.affiliationDepartment of Pulmonology of Central Hospital of Maputo, Maputo, Mozambique, Faculty of Medicine of Eduardo Mondlane University, Maputo, Mozambique.en_US
dc.identifier.affiliationInfectious Disease Translational Research Programme, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singaporeen_US
dc.identifier.affiliationGerman Central Committee Against Tuberculosis (DZK), Berlin, Germany.en_US
dc.identifier.affiliationHospital Muniz and Instituto Vaccarezza, Buenos Aires, Argentina.en_US
dc.identifier.affiliationInfectious Disease Pharmacokinetics Laboratory, College of Pharmacy and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA.en_US
dc.identifier.affiliationUniversidad Autonoma de Nuevo Leon, Facultad de Medicina, Neumología, CIPTIR, Monterrey, Mexico.en_US
dc.identifier.affiliationFaculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.en_US
dc.identifier.affiliationTB/HIV Research Centre, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia,en_US
dc.identifier.affiliationDepartment of Internal Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia,en_US
dc.identifier.affiliationDivision of Respirology and Critical Care, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran/Hasan Sadikin General Hospital, Bandung, Indonesia.en_US
dc.identifier.affiliationUniversity of Texas Health Science Center at Tyler, Tyler, TX, USA.en_US
dc.identifier.affiliationDepartment of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.en_US
dc.identifier.affiliationDepartment of TB & Respiratory Diseases, National Institute of TB & Respiratory Diseases, New Delhi, India.en_US
dc.identifier.affiliationRepublican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus.en_US
dc.identifier.affiliationNational Institute of Tuberculosis, Lung Diseases and Thoracic Surgery, Faculty of Health, Catholic University, Ružomberok, Vyšné Hágy, Slovakia.en_US
dc.identifier.affiliationUniversity of Texas Health Science Center at Tyler, Tyler, TX, USAen_US
dc.identifier.affiliationSchool of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australiaen_US
dc.identifier.affiliationDepartment of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.en_US
dc.identifier.affiliationDepartment of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlandsen_US
dc.identifier.affiliationInfectious Diseases Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant´Orsola, Bologna, Italyen_US
dc.identifier.affiliationDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, USA.en_US
dc.identifier.affiliationBlizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.en_US
dc.identifier.affiliationP. D. Hinduja National Hospital and Medical Research Centre, Mumbai, India.en_US
dc.identifier.affiliationDepartment of Paediatrics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.en_US
dc.identifier.affiliationNational Drug Information and Adverse Drug Reaction Monitoring Centre, Hanoi University of Pharmacy, Hanoi, Vietnam.en_US
dc.identifier.affiliationDepartment of Pulmonary Diseases and Tuberculosis, Groningen, Haren, the Netherlandsen_US
dc.identifier.affiliationWestmead Hospital, Sydney, NSW, Australiaen_US
dc.identifier.affiliationVictorian Infectious Disease Unit, Royal Melbourne Hospital, VIC, Australia.en_US
dc.identifier.affiliationDepartment of Public Health TB Control, Metropolitan Public Health Services, The Hague, The Netherlands.en_US
dc.identifier.affiliationALOSA (Active Learning over Sanitary Aspects) Academy, Spain.en_US
dc.identifier.affiliationDepartement of Infectious Diseases, Karolinska University Hospital, Stockholm, Swedenen_US
dc.identifier.affiliationSouth African Medical Research Council Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africaen_US
dc.identifier.affiliationDepartment of Pediatrics, University of Wisconsin, Madison, WI, USA.en_US
dc.identifier.affiliationServizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Tradate, Italyen_US
dc.identifier.affiliationDepartment of Biomedical Sciences, Division of Pharmacology and Therapy, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.en_US
dc.identifier.affiliationCentre for Tropical Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.en_US
dc.identifier.affiliationDepartment of Medicine, The University of Texas at Tyler School of Medicine, TX, USAen_US
dc.identifier.affiliationDepartment of Clinical Pharmacology and Toxicology, St Vincent´s Hospital, Sydney, NSW, Australia.en_US
dc.identifier.affiliationDepartment of Pharmacy, Uppsala University, Uppsala, Sweden.en_US
dc.identifier.affiliationDepartment of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.en_US
dc.identifier.affiliationInfectious Diseasesen_US
dc.identifier.affiliationTuberculosis Center Beatrixoord, University Medical Center Groningen, University of Groningen, Haren, the Netherlands.en_US
dc.identifier.affiliationSchool of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.en_US
dc.identifier.affiliationFaculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.en_US
dc.identifier.affiliationDivision of Infectious Diseases, Department of Medicine, National University Hospital, Singapore.en_US
dc.identifier.affiliationDepartment of Pharmacy Practice, Texas Tech University Health Science Center, Dallas, TX, USA.en_US
dc.identifier.doi10.5588/ijtld.23.0078en_US
dc.type.contentTexten_US
dc.identifier.pubmedid37353868-
dc.description.volume27-
dc.description.issue7-
dc.description.startpage506-
dc.description.endpage519-
dc.subject.meshtermssecondaryTuberculosis/diagnosis-
dc.subject.meshtermssecondaryTuberculosis/drug therapy-
dc.subject.meshtermssecondaryDrug-Related Side Effects and Adverse Reactions/etiology-
local.name.researcherSrivastava, Piyush M
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.deptMedicine (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

14
checked on Oct 1, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.